Hypoglycemia as a potential risk for patients taking clopidogrel: A systematic review and meta-analysis
BackgroundClopidogrel is a cornerstone antiplatelet drug used in cardiovascular, cerebrovascular, and peripheral artery diseases. The sulfhydryl group of clopidogrel metabolite could induce insulin autoimmune syndrome (IAS) with hypoglycemia as the major symptom. Discontinuing clopidogrel and substi...
Main Authors: | Shi Chen, Jiaqi Qiang, Yuelun Zhang, Bin Zhao, Ran Tian, Tao Yuan, Ming Li, Mei Li, Yuxiu Li, Huijuan Zhu, Hui Pan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1091933/full |
Similar Items
-
Recurrent hypoglycemia induced by clopidogrel: A case report and mini review
by: Weiguan Du, et al.
Published: (2024-03-01) -
Case Report: Recurrent Autoimmune Hypoglycemia Induced by Non-Hypoglycemic Medications
by: Qiuping Zhu, et al.
Published: (2022-07-01) -
Clopidogrel-induced non-diabetic hypoglycemia reported from Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a case report
by: Kibret Enyew Belay, et al.
Published: (2023-11-01) -
Risk of hypoglycemia associated with repaglinide combined with clopidogrel, a retrospective cohort study
by: Yuuki Akagi, et al.
Published: (2020-03-01) -
Autoimmune hypoglycemia
by: Marina Y. Yukina, et al.
Published: (2018-10-01)